SMS Pharmaceuticals has informed that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 a meeting of the Board of Directors of the Company will be held on Saturday, the 28th day of July, 2018, at the Registered Office of the Company, to consider and approve the Unaudited Standalone Quarterly results for Quarter ended on 30th June, 2018. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and company’s Code for Regulation and Prohibition of Insider Trading Trading Window of the company shall remained closed for all the Directors / officers/ Designated Employees/ Promoters of the Company from, 21st July, 2018 to 30th June, 2018. Trading window will be open from 31st July, 2018.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |